Franco Lori

6.8k citations
110 papers · 4.9k indexed · 1 hit paper · h-index 32

Impact in

  • Virology top 0.1%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV Research and Treatment 68
    • HIV/AIDS drug development and treatment 50
    • HIV/AIDS Research and Interventions 23

Franco Lori

106 papers receiving 4.7k citations

Hit Papers

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy 1999 · 1.6k citations
1.6k199920262008201750010001.5k

Peers

Franco Lori
Comparison fields: 5 of 120
  • Virology 3.6k
  • Infectious Diseases 2.7k
  • Immunology 1.4k
  • Epidemiology 992
  • Emergency Medicine 267
Replace Julianna Lisziewicz with:
Julianna Lisziewicz United States
Bharat Ramratnam United States
J Michael Kilby United States
A S Fauci United States
Andrea Cara Italy
Jesus F. Salazar-Gonzalez United States
James E. K. Hildreth United States
Éva Mária Fenyõ Sweden
José A. Esté Spain
Joseph W. Adelsberger United States
Franco Lori relative to Julianna Lisziewicz United States Julianna Lisziewicz's profile →
Citations per field
00.5×1.7×
Julianna Lisziewicz · 1×
Citations per year

Countries citing papers authored by Franco Lori

Since Specialization
Citations

This map shows the geographic impact of Franco Lori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Lori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Lori more than expected).

Fields of papers citing papers by Franco Lori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Lori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Lori. The network helps show where Franco Lori may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Franco Lori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Franco Lori Line = papers co-authored together Franco Lori links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20246
2 20249
3 20232
4 20236
5 20235
6 20204
7 201712
8 200840
9 200810
10 200729
11 20078
12 20059
13 20023
14 200160
15 199928
16 19992
17
Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.
199726
18 199655
19 199553
20 198833

About Franco Lori

Franco Lori is a scholar working on Virology, Infectious Diseases, Immunology, Genetics and Hepatology, having authored 110 papers that have together received 4.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (68 papers), HIV/AIDS drug development and treatment (50 papers), HIV/AIDS Research and Interventions (23 papers), Immunotherapy and Immune Responses (18 papers), Immune Cell Function and Interaction (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (12 papers), T-cell and B-cell Immunology (11 papers) and Hemoglobinopathies and Related Disorders (10 papers). The work is most often cited by research in Virology (3.6k citations), Infectious Diseases (2.7k citations), Immunology (1.4k citations), Epidemiology (992 citations) and Emergency Medicine (267 citations). Franco Lori has collaborated with scholars based in United States, Italy and Hungary. Frequent co-authors include Julianna Lisziewicz, Robert C. Gallo, Andrea Cara, Eric Rosenberg, Bruce D. Walker, Diana Finzi, Robert F. Siliciano, Thomas C. Quinn, Charles Flexner and Stephen J. Gange. Their work appears in journals such as AIDS Research and Human Retroviruses, AIDS, Vaccine, Journal of Virology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026